Concepedia

Author

Mengsha Tong

Fujian Medical University

Also Known As

Meng-Sha Tong, Mengsha Tong, Tong, Mengsha

30

Publications

535

Citations

11

H-Index

36

Concepts

All Affiliations

Fujian Medical UniversityHarbin Medical UniversityXiamen UniversityBeijing Proteome Research CenterPeking University
MT

About

Mengsha Tong is an author at Fujian Medical University specializing in medicine, tumor microenvironment, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

228

2

Engineering

3

3

110

3

Health Sciences

1

1

56

4

Cell Biology

1

1

88

5

Chemical Engineering

1

1

50

Mengsha Tong

×

13

Publications

490

Citations

11

H-Index

YearCitations

Lymphatic-localized Treg-mregDC crosstalk limits antigen trafficking and restrains anti-tumor immunity

Siyuan You, Shuqin Li, Lingsu Zeng,

Cancer Cell

2024

88

Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms

Qingzhou Guan, Rou Chen, Haidan Yan,

Oncotarget

2016

67

An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection

Lu Ao, Xuekun Song, Xiangyü Li,

Oncotarget

2016

56

Determination of tannic acid based on luminol chemiluminescence catalyzed by cupric oxide nanoparticles

Guangwen Li, Lei Hong, Mengsha Tong,

Analytical Methods

2015

50

An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups

Xiangyü Li, Hao Cai, Weicheng Zheng,

Oncotarget

2016

43

Single‐cell RNA‐seq reveals altered NK cell subsets and reduced levels of cytotoxic molecules in patients with ankylosing spondylitis

Conglin Ren, Mingshuang Li, Yang Zheng,

Journal of Cellular and Molecular Medicine

2022

40

Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer

Hao Cai, Xiangyü Li, Jing Li,

Oncotarget

2015

32

Molecular subtyping of cancer and nomination of kinase candidates for inhibition with phosphoproteomics: Reanalysis of CPTAC ovarian cancer

Mengsha Tong, Chunyu Yu, Dongdong Zhan,

EBioMedicine

2018

26

Identifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post- chemotherapy tissues

Mengsha Tong, Weicheng Zheng, Xingrong Lu,

Oncotarget

2015

25

Phosphoproteomics Enables Molecular Subtyping and Nomination of Kinase Candidates for Individual Patients of Diffuse-Type Gastric Cancer

Mengsha Tong, Chunyu Yu, Jinwen Shi,

iScience

2019

24

Page 1